nanoplatin
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2009 (NCT00910741)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- DNACROSS-LINKING AGENT
DNA cross-linking agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nanoplatin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00910741 | Phase 1/Phase 2 (Phase 2) | May 1, 2009 | NanoCarrier Co., Ltd., National Cheng Kung University, Orient Europharma Co., Ltd. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NanoCarrier Co., Ltd. | For profit | 1 | 1 | 1 | 2009 |
| National Cheng Kung University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Orient Europharma Co., Ltd. | For profit | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1